European Pharmaceutical Review

What European Pharmaceutical Review does

European Pharmaceutical Review is a B2B online publication serving pharmaceutical manufacturing professionals, operated by Russell Publishing Limited, a private family-run UK limited company headquartered in Brasted, Kent. Founded in 1996 under the long-running tagline "Leading the conversation in pharma manufacturing," the publication delivers news, technical articles, opinion pieces, and expert interviews across six core verticals: analytical and bioanalysis, bioprocessing and biomanufacturing, quality/microbiology/contamination control, regulation and compliance, formulation and drug delivery, and packaging/containers/labelling.

The core product surface is a digital content management and web publishing platform accessible at europeanpharmaceuticalreview.com, supplemented by a topic A-Z taxonomy, a weekly email newsletter, on-demand and live webinars, the gated Pharma Horizons long-form report series (e.g., Process Analytical Technology and Cell and Gene Therapy issues in 2026), and an annual Future of Bio/Pharmaceutical Analysis Virtual Summit. A freemium membership programme gates premium reports, exclusive webinars, and deep-dive analysis behind registered user accounts, while a sponsorship engine underwrites editorial programming through 20+ named enterprise sponsors across instrumentation, services, standards bodies, and pharma manufacturers.

Revenue is generated primarily through advertising and sponsorship — article sponsorships, webinar sponsorships, and sponsored Pharma Horizons reports from Tier-1 partners including Bruker (SciY), Sartorius, Thermo Fisher Scientific, USP, Pfizer CentreOne, Merck, METTLER TOLEDO, Entegris, FUJIFILM Wako, Shimadzu, and CPhI — combined with a subscription/membership recurring revenue stream from registered users. Customer segments are vertically segmented within pharma: pharmaceutical manufacturing professionals, regulatory affairs specialists, QA/QC professionals, formulation and drug delivery scientists, and bioprocessing/biomanufacturing specialists, with end customers spanning pharma manufacturers, biotech companies, CDMOs, and QA/regulatory functions in life sciences enterprises. Distribution is exclusively digital and global in stated geo-scope, with the publication marketing a single UK base across Europe and global pharmaceutical markets.

Name

European Pharmaceutical Review

Legal name

Russell Publishing Limited

Website

https://europeanpharmaceuticalreview.com

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

101–250 employees

Short description

European Pharmaceutical Review is a B2B online publication serving pharmaceutical manufacturing professionals with news, technical articles, sponsored webinars, long-form Pharma Horizons reports, and an annual virtual summit on pharma manufacturing topics.

Ownership category

akta.pro rank

Product category

Pharmaceutical Trade Publishing and Media

akta.pro primary industry

Scientific & Laboratory Reference (Chemistry, Biology, Physics; Methods & Protocols) (EDAGAGAG)

Keywords

• Pharmaceutical trade media
• Pharma manufacturing news
• Bioprocessing industry coverage
• Regulatory compliance reporting
• Pharmaceutical webinars

Headquarters

HQ city

Kent

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Digital Commerce or Content

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Advertising and Sponsorship: The publication generates revenue primarily through pharmaceutical industry advertising and sponsored content. Article sponsorships, webinar sponsorships, and report sponsorships from pharma companies, CDMOs, and service providers constitute the core commercial model.
2. Membership and Premium Content: Free basic access to news and articles, with premium content including deep-dive reports, exclusive webinars, and in-depth analysis requiring membership registration.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

European Pharmaceutical Review is a B2B online media brand publishing news, articles, opinion pieces, and expert interviews covering pharmaceutical manufacturing, bioprocessing, QA/QC, analytical and bioanalysis, drug delivery, formulation, packaging, and regulatory compliance. Its commercial offering extends beyond the online journal into sponsored webinars, in-depth Pharma Horizons industry reports, an annual virtual summit (Future of Bio/Pharmaceutical Analysis), and a registered membership that unlocks premium reports, exclusive webinar access, and the weekly newsletter.

Product overview

European Pharmaceutical Review is a B2B online publication providing a comprehensive content platform for the pharmaceutical manufacturing industry. The offering consists of a core online publication delivering news, articles, and expert opinions, supplemented by live and on-demand webinars, in-depth Pharma Horizons reports, and virtual summits such as The Future of Bio/Pharmaceutical Analysis. A membership programme provides exclusive access to content, newsletters, and community features.

Differentiator

Problem solved

Functional benefit

Products and services

• European Pharmaceutical Review (Online Publication) Online trade publication delivering news, articles, opinion pieces, and interviews covering pharmaceutical manufacturing, bioprocessing, QA/QC, drug delivery, and regulatory compliance for pharmaceutical industry professionals.
• Industry Webinar Series Live and on-demand webinar series featuring industry expert panels on bioprocessing, downstream processing, pyrogen detection, qPCR automation, Raman spectroscopy, dissolution testing, and aseptic gowning, targeted at pharmaceutical manufacturing and QA/QC professionals.
• Pharma Horizons Industry Reports In-depth sponsored industry reports including Pharma Horizons: Process Analytical Technology (PAT), Pharma Horizons: Cell and Gene Therapy, and Pharma Horizons: leading-edge formulation, providing comprehensive analysis of pharmaceutical manufacturing trends for industry professionals.
• Membership Programme Subscription membership offering unlimited access to industry intelligence, weekly newsletters, exclusive webinar invitations, deep-dive reports, and community access for pharmaceutical industry professionals.
• The Future of Bio/Pharmaceutical Analysis Virtual Summit Annual virtual summit with expert-led sessions covering environmental monitoring, endotoxin testing, nitrosamine compliance, regulatory disruption, and AI-enabled digital transformation in biopharma manufacturing for pharmaceutical industry professionals.

Named customers4 records

Segments5 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

24 partnerships are on record, tiered core and minor.

• Bruker (SciY)coreGTM or Marketing PartnerSponsor of the Pharma Horizons: Process Analytical Technology (PAT) report and webinars on contamination control and PAT in manufacturing.
• SartoriuscoreGTM or Marketing PartnerSponsor of the Pharma Horizons: Cell and Gene Therapy report and webinars on digital PCR sterility testing and bioprocessing automation.
• Pfizer CentreOneminorGTM or Marketing PartnerSponsored webinar on enhancing downstream processing for biologic therapies.
• Thermo Fisher ScientificcoreGTM or Marketing PartnerMultiple webinar sponsorships covering bioprocessing automation, Raman QC for biopharma fill-finish, and eBook content on twin-screw extrusion.
• USP (United States Pharmacopeia)coreGTM or Marketing PartnerSponsored webinars on innovating pharmaceutical manufacturing and dissolution equipment compliance with USP chapters.
• BioDurominorGTM or Marketing PartnerSponsored webinar on crystal solid form optimisation for pharmaceutical development.
• BioRadminorGTM or Marketing PartnerSponsored webinar on enhancing laboratory workflows with qPCR automation.
• TA InstrumentsminorGTM or Marketing PartnerSponsored webinar on how thermal analysis can enhance pharmaceutical drug development.
• METTLER TOLEDOminorGTM or Marketing PartnerSponsored webinar on USP chapters 41 and 1251 revisions for pharma quality control.
• Particle Measuring SystemsminorGTM or Marketing PartnerSponsored webinar on practical considerations for aseptic gowning in contamination control strategies.
• FUJIFILM Wako Pure Chemical CorporationminorGTM or Marketing PartnerSponsored webinar on implementing reporter assay-based MAT for rapid pyrogen detection.
• Lubrizol Advanced Materials Europe BVminorGTM or Marketing PartnerSponsored article on improving patient-centricity with advanced polymer excipients.
• IMA PharmaminorGTM or Marketing PartnerSponsored article on troubleshooting capping defects in brittle tablet formulations.
• OctaveminorGTM or Marketing PartnerSponsored article on what Annex 22 spells for AI in GMP manufacturing.
• Cold Chain TechnologiesminorGTM or Marketing PartnerSponsored article on thermal assurance and pharmaceutical cold chain management.
• CPhIcoreGTM or Marketing PartnerSponsored article on medicines as strategic assets and the politics of pharma supply, with cross-promotion of CPhI Americas event.
• GilsonminorGTM or Marketing PartnerSponsored article on selecting the right qPCR workflow strategy.
• MerckminorGTM or Marketing PartnerSponsored article on how to choose the right microbial air sampler for cleanroom monitoring.
• MBV AGminorGTM or Marketing PartnerSponsored article on the MAS-100 Libra automated passive air sampling system for cleanrooms.
• ShimadzuminorGTM or Marketing PartnerSponsored news article on MultiNA II MCE-301 nucleic acid analysis system.
• Clever Culture SystemsminorGTM or Marketing PartnerSponsored article on intelligent automation in pharmaceutical microbiology.
• EntegrisminorGTM or Marketing PartnerSponsored eBook on single-use filtration in biopharma.
• MastercontrolminorGTM or Marketing PartnerSponsored article on 2024 pharmaceutical industry trends in pharma quality and manufacturing.
• AchemacoreGTM or Marketing PartnerPartnership coverage and article sponsorship for ACHEMA 2024 pharmaceutical technology trends.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• BioPharm International: Long-running B2B media brand covering pharmaceutical development, manufacturing, and QA/QC targeting pharma professionals. Closest direct competitor in scope and audience to EPR.
• Pharmaceutical Technology: Multi-decade pharma manufacturing publication from Informa covering formulation, manufacturing, QA/QC, regulatory, and packaging — nearly identical topical coverage to EPR with similar B2B sponsorship model.
• Drug Target Review: Sister publication under Russell Publishing covering drug discovery and target identification — directly comparable model, audience overlap with EPR, and shared operating leverage from same parent company.
• Outsourced Pharma: Specialist B2B media outlet focused on CDMOs, contract manufacturing, and pharma outsourcing — same audience (manufacturing and regulatory professionals) with strong overlap on EPR's CDMO and bioprocessing coverage.
• BioProcess International (BPI): Informa-owned publication focused specifically on bioprocessing, biologics manufacturing, and cell/gene therapy — overlaps with EPR's Bioprocessing and Biomanufacturing and Cell & Gene Therapy editorial pillars.
• Pharma Manufacturing Magazine: Endeavor Business Media brand covering pharma manufacturing, QA/QC, packaging, and regulatory — directly comparable editorial scope and B2B sponsorship revenue model to EPR.

Broad incumbents

• Informa Pharma Intelligence: Much larger pharma intelligence and media portfolio from Informa including CPHI, Pharma Intelligence, and BioProcess International — broader scale, deeper data products, and event portfolio than EPR but competes for same advertising and audience budgets.
• Reuters Events Pharma: Large pharma events and content brand operating at global scale with deeper event budgets and broader sponsor base — direct competitor for pharma manufacturing executive attention and sponsorship dollars.
• Applied Clinical Trials: Specialist pharma clinical and regulatory media brand from MJH Life Sciences — comparable B2B publishing model but skewed toward clinical rather than manufacturing audiences.

Emerging players

• GEN (Genetic Engineering & Biotechnology News): Mary Ann Liebert publication covering biotechnology including bioprocessing, cell therapy, and biomanufacturing — overlaps with EPR's bioprocessing and cell/gene therapy coverage with broader biotech scope.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights6 records

Customer concentration

• Xx.com/PharmaReview
• Facebookfacebook.com/EuropeanPharmaceuticalReview

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about European Pharmaceutical Review